Healthcare Activos has transformed a loan of €390 million into sustainable financing. The real estate assets and socio-sanitary equipment company has obtained the loan for a period of five years and has the participation of twelve banks,
The operation has been led by Crédit Agricole CIB, which has contemplated a reduction in financial costs or a penalty based on compliance with a series of measurably sociable criteria.
In order for the sustainable financing credit to have been approved, Healthcare Activos has obtained the endorsement of Moody’s agency, which has given the highest possible rating to its social management principles. The firm is the first real estate agency in Europe to receive a social rating within the framework of its financing.
If you want to read more about Healthcare Activos and find the most important financial news of the day, download for free our companion app Born2Invest.
Healthcare Activos has obtained sustainable financing thanks to the endorsement of Moody’s
“The company is committed to the health sector, playing an active role in the sustainable environmental development of infrastructures, taking care of the most fragile people in society, and guaranteeing compliance beyond legal requirements,” Moody’s mentions.
Healthcare Activos has a portfolio of sixty assets in Spain, Portugal, Germany, and Belgium, mainly buildings for nursing homes and, to a lesser extent, hospitals and clinics. In addition, it has fourteen residences in Spain in the development phase, whose management will be in charge of specialized operators.
The next facilities to be delivered by the company are in Terrassa (Barcelona) and Córdoba (Andalusia), and will be operated by DomusVi and Orpea, respectively. On average, each nursing home has between 120 and 140 beds and represents an investment of between fourteen million and fifteen million euros.
Since its creation in 2016, Healthcare Activos has acquired more than fifty assets in Spain and Portugal, of which forty are operational and ten are in the development phase.
With Jorge Guarner as founder and president and Albert Fernández as CEO, the platform is based on long-term business fundamentals: selected assets, leased to the main European operators with triple net long-term contracts and inflation-indexed fixed income.
DISCLAIMER: This article was written by a third party contributor and does not reflect the opinion of Born2Invest, its management, staff or its associates. Please review our disclaimer for more information.
This article may include forward-looking statements. These forward-looking statements generally are identified by the words “believe,” “project,” “estimate,” “become,” “plan,” “will,” and similar expressions. These forward-looking statements involve known and unknown risks as well as uncertainties, including those discussed in the following cautionary statements and elsewhere in this article and on this site. Although the Company may believe that its expectations are based on reasonable assumptions, the actual results that the Company may achieve may differ materially from any forward-looking statements, which reflect the opinions of the management of the Company only as of the date hereof. Additionally, please make sure to read these important disclosures.
First published in PlantaDoce, a third-party contributor translated and adapted the article from the original. In case of discrepancy, the original will prevail.
Although we made reasonable efforts to provide accurate translations, some parts may be incorrect. Born2Invest assumes no responsibility for errors, omissions or ambiguities in the translations provided on this website. Any person or entity relying on translated content does so at their own risk. Born2Invest is not responsible for losses caused by such reliance on the accuracy or reliability of translated information. If you wish to report an error or inaccuracy in the translation, we encourage you to contact us.
Jazz Pharmaceuticals’ Leukemia Drug Receives European Commission Approval
Jazz Pharmaceuticals is a biopharmaceutical company dedicated to the development of drugs in neuroscience and oncology. Founded in 2003 in...
Citi Announced a $6 Million Loan to Sempli for SME financing
The credit granted by Citi was given in partnership with high-impact investors and multilateral development organizations. They all seek to...
How Will the Price of Ripple and Cardano Develop in the Next Few Days
The BOLL indicator shows no specific pattern and denotes the support price of $0.4969 and the resistance price of $0.5059,...
RADEEF: a 182 Million Dirham Plan to Combat Flooding in Morocco
RADEEF is also planning major expansion projects. Firstly, it plans to launch work on extending the wastewater treatment plant. The...
How Institutional Investors Feel About Impact Investing
Investors continue to face greenwashing when implementing impact investing. Among their key concerns are misleading or exaggerated impact claims (60%),...
Fintech2 weeks ago
Fintech Company Cleafy Raises €10 million
Crypto1 day ago
Coinbase Now Holds as Much Bitcoin as Satoshi Nakamoto, Arkham Reveals
Crypto1 week ago
Ripple’s IPO Plans – What Do They Mean for XRP?
Biotech2 weeks ago
Murcia Puts Out to Tender for €500,000 the Works of the Clinical Trials Unit in Arrixaca